SANOFI-AVENTIS (EPA:SAN)

BRIEF

published on 05/19/2026 at 18:42, 5 months 13 days ago

Sanofi Reports Voting Rights and Share Information for April 2026

Voting Rights French Commercial Code Shares Sanofi April 2026
PRESS RELEASE

published on 05/19/2026 at 18:37, 5 months 13 days ago

Sanofi: Information concerning the total number of voting rights and shares - April 2026
Sanofi discloses total voting rights and shares information as per French Commercial Code and French stock market authority regulations

French Commercial Code Total Voting Rights Shares Information Sanofi Stock Market Authority
BRIEF

published on 05/18/2026 at 21:35, 5 months 14 days ago

Sanofi announces the superiority of efdoralprin alfa in the treatment of DAAT

Sanofi Phase 2 DAAT Efdoralprin Alfa Recombinant Treatment
PRESS RELEASE

published on 05/18/2026 at 21:30, 5 months 14 days ago

Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD
ElevAATe phase 2 study shows efdoralprin alfa surpassing traditional therapy in achieving and maintaining fAAT levels in AATD patients with emphysema. Results presented at 2026 ATS International Conference

Efdoralprin Alfa ElevAATe FAAT Levels AATD Emphysema
BRIEF

published on 04/24/2026 at 20:35, 6 months 7 days ago

Sanofi Prices €2.3 Billion in Bond Offering

Corporate Finance Bond Issue Sanofi Fixed-rate Notes Euro Medium Term Note
PRESS RELEASE

published on 04/24/2026 at 20:30, 6 months 7 days ago

Press Release: Sanofi successfully prices 2.3 billion of bond issue
Sanofi successfully prices €2.3 billion bond issue with notes across 3 tranches under Euro Medium Term Note programme. Net proceeds for general corporate purposes

Bond Issue Corporate Purposes Sanofi Euro Medium Term Note Global Coordinators
BRIEF

published on 04/24/2026 at 12:14, 6 months 7 days ago

Sanofi's Cenrifki Receives Positive CHMP Opinion for SPMS

Sanofi HERCULES Study CHMP Recommendation Cenrifki Approval SPMS Treatment
BRIEF

published on 04/24/2026 at 12:14, 6 months 7 days ago

Sanofi receives a favorable opinion for tolebrutinib in the treatment of multiple sclerosis

Multiple Sclerosis Approval Sanofi Tolebrutinib CMUH
PRESS RELEASE

published on 04/24/2026 at 12:09, 6 months 7 days ago

Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses
CHMP recommends EU approval for Sanofi's Cenrifki (tolebrutinib) to treat secondary progressive multiple sclerosis without relapses. Positive opinion based on HERCULES phase 3 study

Multiple Sclerosis Sanofi CHMP Tolebrutinib Cenrifki
BRIEF

published on 04/22/2026 at 23:35, 6 months 9 days ago

Sanofi and Regeneron Win FDA Approval for Dupixent in Young Children

FDA Approval Sanofi Dupixent Regeneron Pediatric Medicine

Published on 10/30/2026 at 23:35, 2 days 9 hours ago

Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 2 days 9 hours ago

Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 20:47, 2 days 12 hours ago

CoTec Holdings Corp. Comments on Share Trading
Published on 10/30/2026 at 19:00, 2 days 14 hours ago

Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days 17 hours ago

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split

View all ACCESSWIRE

Published on 11/02/2026 at 08:57, 8 minutes ago

Original-Research: Rainbow Tours S.A. (von East Value Research GmbH ): BUY
Published on 11/02/2026 at 08:49, 16 minutes ago

Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 11/02/2026 at 08:45, 20 minutes ago

Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 11/02/2026 at 08:42, 23 minutes ago

Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 11/02/2026 at 08:30, 35 minutes ago

Suspension: Wildcat Gold Plc

View all EQS

Published on 10/30/2026 at 23:00, 2 days 10 hours ago

BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 20:42, 2 days 12 hours ago

TINC and PMV invest in Storm Group (B)
Published on 10/30/2026 at 18:00, 2 days 15 hours ago

2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 12:00, 2 days 21 hours ago

Capital increase through exercise of subscription rights
Published on 10/30/2026 at 08:45, 3 days ago

Share buyback

View all LES ECHOS COMFI WIRE

News